Drug intelligence / Profile preview

PNU74654

Development stage
Preclinical
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

PNU74654 is a small molecule inhibitor that specifically disrupts the interaction between β-catenin and T-cell factor (TCF) transcription factors, particularly TCF4. By binding to the armadillo repeat domain of β-catenin, it prevents the formation of the β-catenin/TCF complex, thereby inhibiting the transcription of Wnt signaling target genes. In the context of oncology research, it has been shown to suppress the activation of cancer-associated fibroblasts (CAFs) and reduce the expression of periostin (POSTN), which in turn sensitizes melanoma cells to targeted therapies like BRAF inhibitors. It is primarily used as a chemical probe in preclinical studies to investigate Wnt/β-catenin signaling pathways in various cancers, including colorectal and breast cancer.

Other names
5-methyl-2-phenyl-4-[(phenylamino)methyl]-2,4-dihydro-3H-pyrazol-3-one
02

Targets

CTNNB1 (Beta-catenin)

Beyond the preview

Go deeper on PNU74654.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PNU74654.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call